Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) - 26/08/11
, Joel M Gore, MD a, Fredrick A Anderson, PhD a, Andrzej Budaj, MD, PhD b, Shaun G Goodman, MD c, Ávaro Avezum, MD d, José López-Sendón, MD e, Werner Klein, MD f, Debabrata Mukherjee, MD g, Kim A Eagle, MD g, Omar H Dabbous, MD, MPH a, Robert J Goldberg, MD aGRACE Investigators
Abstract |
Objective |
To examine the association between elevated leukocyte count and hospital mortality and heart failure in patients enrolled in the multinational, observational Global Registry of Acute Coronary Events (GRACE).
Background |
Elevated leukocyte count is associated with adverse hospital outcomes in patients presenting with acute myocardial infarction (AMI). The association of this prognostic factor with hospital mortality and heart failure in patients with other acute coronary syndromes (ACS) is unclear.
Methods |
We examined the association between admission leukocyte count and hospital mortality and heart failure in 8269 patients presenting with an ACS. This association was examined separately in patients with ST-segment elevation AMI, non-ST–segment elevation AMI, and unstable angina. Leukocyte count was divided into 4 mutually exclusive groups (Q): Q1 <6000, Q2 = 6000–9999, Q3 = 10,000–11,999, Q4 >12,000. Multiple logistic regression analysis was performed to examine the association between elevated leukocyte count and hospital events while accounting for the simultaneous effect of several potentially confounding variables.
Results |
Increasing leukocyte count was significantly associated with hospital death (adjusted odds ratio [OR] 2.8, 95% CI 2.1–3.6 for Q4 compared to Q2 [normal range]) and heart failure (OR 2.7, 95% CI 2.2–3.4) for patients presenting with ACS. This association was seen in patients with ST-segment elevation AMI (OR for hospital death 3.2, 95% CI 2.1–4.7; OR for heart failure 2.4, 95% CI 1.8–3.3), non-ST–segment elevation AMI (OR for hospital death 1.9, 95% CI 1.2–3.0; OR for heart failure 1.7, 95% CI 1.1–2.5), or unstable angina (OR for hospital death 2.8, 95% CI 1.4–5.5; OR for heart failure 2.0, 95% CI 0.9–4.4).
Conclusion |
In men and women of all ages with the spectrum of ACS, initial leukocyte count is an independent predictor of hospital death and the development of heart failure.
Le texte complet de cet article est disponible en PDF.Plan
| ☆ | The GRACE project is supported by an unrestricted educational grant from Aventis Pharma (Bridgewater, NJ). Guest Editor for this manuscript was Raymond J. Gibbons, MD, Mayo Clinic, Rochester, Minn. |
Vol 147 - N° 1
P. 42-48 - janvier 2004 Retour au numéro
Article précédent
- Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care: which mode is quicker?
- Caroline B Hutchings, N.Clay Mann, Mohamud Daya, Jon Jui, Robert Goldberg, Lawton Cooper, David C Goff, Carol Cornell, Rapid Early Action for Coronary Treatment (REACT) Study
- Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients
- Lars Gullestad, Jonathan Myers, Thor Edvardsen, John Kjekshus, Odd Geiran, Svein Simonsen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?